세계의 미용 주사제(보톡스) 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2032년)

The global demand for Aesthetic Injectables Market is presumed to reach the market size of nearly USD 37.64 Billion by 2032 from USD 14.36 Billion in 2023 with a CAGR of 11.3% under the study period 2024 - 2032.

Aesthetic injectables are cosmetic treatments involving the injection of substances like botulinum toxin (Botox), dermal fillers, or neurotoxins to enhance facial aesthetics. These injectables are used to reduce wrinkles, restore volume, and improve overall skin appearance.

MARKET DYNAMICS

The aesthetic injectables market is propelled by scaling demand for non-invasive cosmetic procedures, advancements in injectable technologies, and the increasing emphasis on appearance enhancement. Aesthetic injectables, including dermal fillers and botulinum toxin products, offer minimally invasive solutions for wrinkle reduction, facial contouring, and skin rejuvenation. The desire for youthful and natural-looking results without surgical intervention drives the popularity of aesthetic injectables. The social media influence, celebrity endorsements, and the acceptance of cosmetic procedures contribute to the expanding consumer base. Additionally, technological innovations, such as longer-lasting formulations and improved safety profiles, contribute to market growth. The rise in disposable income and the change in societal attitudes towards aging further fuel the demand for aesthetic injectables, making them integral to the evolving landscape of the global beauty and cosmetic industry.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aesthetic injectables. The growth and trends of aesthetic injectables industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the aesthetic injectables market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Botulinum Toxin (Botulinum Toxin A, Botulinum Toxin B)
• Dermal Fillers (Product (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres (Pmma), Collagen, Fat Fillers, Other Dermal Fillers), Application (Face Lift, Facial Correction, Wrinkles Reduction, Acne Scar, Lipoatrophy, Lip Enhancement, Hip Augmentation, Breast Enhancement, Hand Rejuvenation, Penis Enlargement, Blepharoplasty, Neck & Chin Lift, Other))

By Gender

• Female
• Male

By Age Group

• 15 - 30
• 31 - 40
• 41 - 50
• 51 - 60
• >60

By End-User

• Hospitals
• Dermatology Clinics
• Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Aesthetic Injectables market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Aesthetic Injectables market include AbbVie Inc. (Allergan Plc.), Bio-Med Private Limited, Bioxis Pharmaceuticals, Cytophil, Inc., Galderma S.A., Ipsen SA, Laboratories Vivacy SAS, Merz Pharma GmbH & Co. KGaA., Mesoestetic, Sinclair Pharma (Huadong Medicine Co., Ltd.), Suneva Medical, Inc., Teoxane Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . AESTHETIC INJECTABLES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Gender
  • 3.7.3 Market Attractiveness Analysis By Age Group
  • 3.7.4 Market Attractiveness Analysis By End-user
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY TYPE

• 5.1 Overview by Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Type
• 5.4 Botulinum Toxin (Botulinum Toxin A, Botulinum Toxin B) Historic and Forecast Sales by Regions
• 5.5 Dermal Fillers (Product (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Collagen, Fat Fillers, Other Dermal Fillers), Application (Face Lift, Facial Correction, Wrinkles Reduction, Acne Scar, Lipoatrophy, Lip Enhancement, Hip Augmentation, Breast Enhancement, Hand Rejuvenation, Penis Enlargement, Blepharoplasty, Neck & Chin Lift, Other)) Historic and Forecast Sales by Regions

6 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY GENDER

• 6.1 Overview by Gender
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Gender
• 6.4 Female Historic and Forecast Sales by Regions
• 6.5 Male Historic and Forecast Sales by Regions

7 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY AGE GROUP

• 7.1 Overview by Age Group
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Age Group
• 7.4 15 - 30 Historic and Forecast Sales by Regions
• 7.5 31 - 40 Historic and Forecast Sales by Regions
• 7.6 41 - 50 Historic and Forecast Sales by Regions
• 7.7 51 - 60 Historic and Forecast Sales by Regions
• 7.8 >60 Historic and Forecast Sales by Regions

8 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY END-USER

• 8.1 Overview by End-user
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-user
• 8.4 Hospitals Historic and Forecast Sales by Regions
• 8.5 Dermatology Clinics Historic and Forecast Sales by Regions
• 8.6 Other Historic and Forecast Sales by Regions

9 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE AESTHETIC INJECTABLES COMPANIES

• 10.1. Aesthetic Injectables Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF AESTHETIC INJECTABLES INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. AbbVie Inc. (Allergan Plc.)
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Bio-Med Private Limited
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Bioxis Pharmaceuticals
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Cytophil Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Galderma S.A.
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Ipsen SA
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Laboratories Vivacy SAS
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Merz Pharma GmbH & Co. KGaA.
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Mesoestetic
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. Sinclair Pharma (Huadong Medicine Co. Ltd.)
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments
• 11.13. Suneva Medical Inc.
  • 11.13.1. Company Overview
  • 11.13.2. Company Revenue
  • 11.13.3. Products
  • 11.13.4. Recent Developments
• 11.14. Teoxane Laboratories
  • 11.14.1. Company Overview
  • 11.14.2. Company Revenue
  • 11.14.3. Products
  • 11.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies